Overexpression of lecithin:cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis.
暂无分享,去创建一个
R. F. Hoyt | J. Cornhill | J. Hoeg | E. Herderick | S. Feldman | C. Haudenschild | S. Marcovina | A. Bérard | S. Demosky | S. Santamarina-Fojo | B. Vaisman | H. Brewer | S. Feldman | C. Hazel | R. Kauffman | J. Hoeg | Annie M. BE'RARD | Edward E. HERDERICKt | Christina M. Hazel | Santica M. Marcovinas
[1] R. F. Hoyt,et al. Lecithin:Cholesterol Acyltransferase Overexpression Generates Hyperalpha-lipoproteinemia and a Nonatherogenic Lipoprotein Pattern in Transgenic Rabbits (*) , 1996, The Journal of Biological Chemistry.
[2] J. Kastelein,et al. Two novel molecular defects in the LCAT gene are associated with fish eye disease. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[3] E. Rubin,et al. Expression of human lecithin-cholesterol acyltransferase in transgenic mice. Effect of human apolipoprotein AI and human apolipoprotein all on plasma lipoprotein cholesterol metabolism. , 1995, The Journal of clinical investigation.
[4] R. F. Hoyt,et al. Overexpression of Human Lecithin Cholesterol Acyltransferase Leads to Hyperalphalipoproteinemia in Transgenic Mice (*) , 1995, The Journal of Biological Chemistry.
[5] H. Klein,et al. In Vitro Expression of Structural Defects in the Lecithin-Cholesterol Acyltransferase Gene (*) , 1995, The Journal of Biological Chemistry.
[6] J. Breslow,et al. Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[7] P. Giral,et al. A cell culture system for screening human serum for ability to promote cellular cholesterol efflux. Relations between serum components and efflux, esterification, and transfer. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[8] U. Goldbourt,et al. Genetic factors in coronary heart disease , 1994, Developments in Cardiovascular Medicine.
[9] D. Rader,et al. Increased production of apolipoprotein A-I associated with elevated plasma levels of high-density lipoproteins, apolipoprotein A-I, and lipoprotein A-I in a patient with familial hyperalphalipoproteinemia. , 1993, Metabolism: clinical and experimental.
[10] A. Tall. Plasma cholesteryl ester transfer protein. , 1993, Journal of lipid research.
[11] H. Klein,et al. Fish eye syndrome: a molecular defect in the lecithin-cholesterol acyltransferase (LCAT) gene associated with normal alpha-LCAT-specific activity. Implications for classification and prognosis. , 1993, The Journal of clinical investigation.
[12] J. Albers,et al. Lipid transfer protein-mediated distribution of HDL-derived cholesteryl esters among plasma apo B-containing lipoprotein subpopulations. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.
[13] R. Ross. The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.
[14] D. Rader,et al. Two different allelic mutations in the lecithin:cholesterol acyltransferase (LCAT) gene resulting in classic LCAT deficiency: LCAT (tyr83-->stop) and LCAT (tyr156-->asn). , 1993, Journal of lipid research.
[15] R. Virmani,et al. Cocaine: an independent risk factor for aortic sudanophilia. A preliminary report. , 1992, Atherosclerosis.
[16] J. Fruchart,et al. Apolipoprotein A-containing lipoprotein particles: physiological role, quantification, and clinical significance. , 1992, Clinical chemistry.
[17] R. Krauss,et al. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI , 1991, Nature.
[18] L. Fong,et al. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. , 1990, Biochimica et biophysica acta.
[19] V. Fuster,et al. Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit. , 1990, The Journal of clinical investigation.
[20] G. Schonfeld,et al. Genetic heterogeneity of lipoproteins in inbred strains of mice: analysis by gel-permeation chromatography. , 1990, Metabolism: clinical and experimental.
[21] A. Tall,et al. Atherogenic diet increases cholesteryl ester transfer protein messenger RNA levels in rabbit liver. , 1990, The Journal of clinical investigation.
[22] D. Gordon,et al. High-density lipoprotein--the clinical implications of recent studies. , 1989, The New England journal of medicine.
[23] A. Chobanian,et al. Influence of Hypertension on Aortic Atherosclerosis in the Watanabe Rabbit , 1989, Hypertension.
[24] M. Cheung,et al. In vitro transformation of apoA-I-containing lipoprotein subpopulations: role of lecithin:cholesterol acyltransferase and apoB-containing lipoproteins. , 1989, Journal of lipid research.
[25] P. Grimaldi,et al. HDL receptor and reverse cholesterol transport in adipose cells. , 1988, Advances in experimental medicine and biology.
[26] J. Fruchart,et al. Cholesterol efflux from cultured adipose cells is mediated by LpAI particles but not by LpAI:AII particles. , 1987, Biochemical and biophysical research communications.
[27] D. Gordon,et al. High-density lipoprotein cholesterol and coronary heart disease in hypercholesterolemic men: the Lipid Research Clinics Coronary Primary Prevention Trial. , 1986, Circulation.
[28] P. Wilson,et al. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. , 1986, JAMA.
[29] J. Brunzell,et al. Human adipose tissue lipoprotein lipase: changes with feeding and relation to postheparin plasma enzyme. , 1985, The American journal of physiology.
[30] J. Albers,et al. Isolation and Characterization of Human Plasma Lipid Transfer Proteins , 1984, Arteriosclerosis.
[31] J. Albers,et al. Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. , 1982, Clinical chemistry.
[32] P. Wahl,et al. Population-based reference values for lecithin-cholesterol acyltransferase (LCAT). , 1982, Atherosclerosis.
[33] P. Barter,et al. Differences in plasma cholesteryl ester transfer activity in sixteen vertebrate species. , 1982, Comparative biochemistry and physiology. B, Comparative biochemistry.
[34] M C Hjortland,et al. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. , 1977, The American journal of medicine.
[35] P. Nestel,et al. Relationships between plasma lipoprotein cholesterol concentrations and the pool size and metabolism of cholesterol in man. , 1976, Atherosclerosis.
[36] A. Børresen. HIGH DENSITY LIPOPROTEIN (HDL) POLYMORPHISMS IN RABBIT I. A COMPARATIVE STUDY OF RABBIT AND HUMAN SERUM HIGH DENSITY LIPOPROTEIN , 1976, Journal of immunogenetics.
[37] A. Børresen. HIGH DENSITY LIPOPROTEIN (HDL) POLYMORPHISMS IN RABBIT II. A STUDY OF THE INHERITED HI 1 AND R 67 ANTIGENS IN RELATION TO HDL POLYPEPTIDES , 1976, European journal of immunogenetics.
[38] A. Børresen. HIGH DENSITY LIPOPROTEIN (HDL) POLYMORPHISMS IN RABBIT III. QUANTITATIVE DETERMINATION OF HDL AND THE INHERITED H1 1 AND R 67 ANTIGENS , 1976, Journal of immunogenetics.
[39] A. Børresen,et al. SERUM-HIGH-DENSITY-LIPOPROTEIN AND ATHEROSCLEROTIC HEART-DISEASE , 1976, The Lancet.
[40] A Kagan,et al. Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men. , 1976, The New England journal of medicine.
[41] Miller Kl. Post delivery care of the edentulous geriatric patient. , 1975 .
[42] J. Glomset,et al. The plasma lecithins:cholesterol acyltransferase reaction. , 1968, Journal of lipid research.
[43] J. Glomset,et al. Role of plasma lecithin:cholesterol acyltransferase in the metabolism of high density lipoproteins. , 1966, Journal of lipid research.
[44] J. Folch,et al. A simple method for the isolation and purification of total lipides from animal tissues. , 1957, The Journal of biological chemistry.
[45] O. H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.